O'Neill Leaves Job To Care For Wife
Martin O'Neill, captain of the Celtic football (US: soccer) club and former Northern Ireland captain, is stepping down from his job to take care of his wife Geraldine who has had a recurrence of lymphoma.
O'Neill said yesterday he was leaving the club "purely for personal reasons". He added: "We have had discussions for some weeks as we awaited certain biopsy results. We have had suspicions in recent weeks and that has taken it to a different level but she wouldn't like me to go into too much detail. We had some good news at the back end of last year and she is not too clever at the minute. I don't have a monopoly of bad times but it is the correct thing to do. She has stood with me for quite some time so this is the right thing."
Mr. O'Neill has been active in raising money for cancer charities in the UK. Article
More Articles
More Articles
Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...
The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...
Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...
At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...
Site Beginnings
This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...
Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...
The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...
The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...
The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...
According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...
Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...
New research suggests that frontline radioimmunotherapy...
Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...
